Home › Head and Neck Squamous Cell Carcinoma › Michigan › Lansing
Head and Neck Squamous Cell Carcinoma clinical trials in Lansing, MI
4 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- University of Michigan Health - Sparrow Lansing, Lansing
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Philadelphia, PA26 studies
- Arlington, VA26 studies
- Chicago, IL25 studies
- Atlanta, GA23 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
Other studies in Lansing
- Lung Cancer11 studies
- Breast Cancer10 studies
- Prostate Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)7 studies
- Disorders of Excessive Somnolence5 studies
- Laryngeal Cancer5 studies
- Bladder Cancer5 studies
- Sleep Disorders4 studies
- Colorectal Cancer4 studies
- Hypopharyngeal Cancer4 studies
- Oral Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.